Monopar Therapeutics Inc (MNPR)
0.65
-0.01
(-1.53%)
USD |
NASDAQ |
May 01, 16:00
0.66
+0.01
(+1.54%)
Pre-Market: 20:00
Monopar Therapeutics Shareholders Equity (Quarterly): 5.588M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.588M |
| September 30, 2023 | 6.611M |
| June 30, 2023 | 7.837M |
| March 31, 2023 | 8.945M |
| December 31, 2022 | 10.09M |
| September 30, 2022 | 12.51M |
| June 30, 2022 | 14.52M |
| March 31, 2022 | 16.97M |
| December 31, 2021 | 18.94M |
| September 30, 2021 | 21.28M |
| June 30, 2021 | 23.35M |
| March 31, 2021 | 25.10M |
| December 31, 2020 | 15.69M |
| Date | Value |
|---|---|
| September 30, 2020 | 17.49M |
| June 30, 2020 | 12.15M |
| March 31, 2020 | 12.40M |
| December 31, 2019 | 12.63M |
| September 30, 2019 | 4.625M |
| June 30, 2019 | 5.127M |
| March 31, 2019 | 5.774M |
| December 31, 2018 | 6.918M |
| September 30, 2018 | 7.576M |
| June 30, 2018 | 8.124M |
| March 31, 2018 | 8.858M |
| December 31, 2017 | 9.619M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.625M
Minimum
Sep 2019
25.10M
Maximum
Mar 2021
13.26M
Average
12.51M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Motus GI Holdings Inc | 2.687M |
| SeaStar Medical Holding Corp | -13.87M |
| Perspective Therapeutics Inc | 75.18M |
| Electromed Inc | 40.34M |
| Xtant Medical Holdings Inc | 51.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.345M |
| Total Liabilities (Quarterly) | 1.757M |